Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PharmaEssentia
PharmaEssentia
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Besremi
Ropeginterferon alfa-2b
2021-11-12
Polycythemia vera
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ropeginterferon alfa-2b
hepatitis b
,
chronic hepatitis
,
healthy volunteers/patients
,
chronic hepatitis d
,
myeloid leukemia chronic-phase
,
hepatitis
,
hepatitis a
,
hepatitis d
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
coinfection
,
primary myelofibrosis
,
essential thrombocythemia
,
thrombocytosis
,
chronic hepatitis b
,
hepatitis c
,
chronic hepatitis c
,
infections
,
communicable diseases
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
covid-19
,
polycythemia
,
polycythemia vera
,
myeloproliferative disorders
,
herpesviridae infections
,
splenomegaly
Benzocaine
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
macular degeneration
,
macular edema
,
edema
,
wet macular degeneration
,
choroidal neovascularization
,
pathologic neovascularization
,
lupus nephritis
,
nephritis
,
retinal vein occlusion
,
diabetic nephropathies
,
leukemia
,
renal cell carcinoma
,
carcinoma
,
bcr-abl positive chronic myelogenous leukemia
,
melanoma
,
myeloid leukemia
,
myasthenia gravis
,
muscle weakness
,
neoplasm metastasis
,
myopia
,
retinal neovascularization
,
anemia
,
chronic renal insufficiency
,
kidney diseases
,
kidney transplantation
,
chronic kidney failure
Calcium carbonate
renal insufficiency
,
hyperphosphatemia
Albumin
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
neoplasm metastasis
Ademetionine
lymphoma
,
myeloid leukemia chronic-phase
,
myeloid leukemia
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
pancreatic neoplasms
,
carcinoma
,
vitiligo
,
b-cell lymphoma
,
glioblastoma
,
glioma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
colorectal neoplasms
,
breast neoplasms
,
lung neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
neoplasms
,
hidradenitis suppurativa
,
hidradenitis
,
lichen sclerosus et atrophicus
,
lichen planus
,
adenosquamous carcinoma
,
asthma
,
cholangiocarcinoma
,
polycythemia vera
,
myeloproliferative disorders
,
primary myelofibrosis
,
polycythemia
Tenofovir
hepatitis c
,
virus diseases
,
breast feeding
,
pregnancy
,
hiv infections
,
acquired immunodeficiency syndrome
,
infections
,
communicable diseases
,
immunologic deficiency syndromes
,
hiv
,
sarcoma
,
kaposi sarcoma
,
hepatitis b
,
hepatitis
,
hepatitis a
,
liver cirrhosis
,
fibrosis
,
biliary liver cirrhosis
,
lipodystrophy
Albinterferon alfa-2b
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
hepatitis b
,
chronic hepatitis b
,
chronic hepatitis
,
melanoma
Fendrix
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use